Cerecor Inc (CERC) stock is up 3.35% over the past week and gets a Neutral rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With CERC Stock Today?
Cerecor Inc (CERC) stock is trading at $2.78 as of 1:56 PM on Tuesday, Dec 22, a gain of $0.12, or 4.32% from the previous closing price of $2.66. Volume today is more active than usual. So far 2,081,891 shares have traded compared to average volume of 240,177 shares. The stock has traded between $2.61 and $3.10 so far today.
To screen for more stocks like Cerecor Inc click here.
More About Cerecor Inc
Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred, Ulesfia, Karbinal ER, AcipHex Sprinkle and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber.
Click Here to get the full Stock Score Report on Cerecor Inc (CERC) Stock.
